India Infection Control Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends (2026-2035)

The India infection control market was valued at USD 1.96 Billion in 2025 driven by rising technological advancements for solutions across the region. It is expected to grow at a CAGR of 4.30% during the forecast period of 2026-2035 and attain a market value of USD 2.99 Billion by 2035. Rising medical tourism in India boosts demand for high-standard infection control. Government initiatives like Swachh Bharat and Ayushman Bharat promote hygienic healthcare delivery. Emerging healthcare facilities in Tier 2 and Tier 3 cities offer untapped market potential.

Q1 2026 Market Updates

The US-Israel-Iran conflict, which escalated with joint airstrikes on 28 February 2026, is raising costs for the India infection control market. Infection control products including disinfectants, antiseptics, sterilization chemicals, and personal protective equipment (PPE) rely on petrochemical-derived raw materials. India imports approximately 60% of its crude oil from the Middle East, and Brent crude above USD 110 per barrel is increasing input costs.

Alcohol-based hand sanitizers and surface disinfectants use isopropanol and ethanol, both of which have cost linkages to crude oil. Chlorine-based disinfectants face rising production costs as the energy-intensive chlor-alkali process becomes more expensive with higher electricity and gas prices. Qatar supplies 50% of India's LNG, and constrained gas availability is affecting chemical manufacturing operations.

PPE manufacturing, including surgical masks, gowns, and gloves, depends on polypropylene and synthetic rubber, both petrochemical derivatives. Synthetic rubber prices have spiked approximately 20% since the conflict began. Shipping rerouting around the Cape of Good Hope adds close to USD 933,000 per voyage, increasing costs for imported sterilization equipment and specialty infection control chemicals.

India's healthcare sector faces the challenge of maintaining infection control standards while managing rising procurement costs. Hospital infection prevention budgets are under pressure as pharmaceutical, medical device, and infection control product costs all escalate simultaneously from the conflict-related supply chain disruptions.

Key Takeaways

Government: India's dependence on Middle Eastern energy (60% of crude, 50% of LNG from Qatar) is raising costs for petrochemical-based infection control products. Government health budgets for infection prevention programs face pressure from simultaneous cost increases across pharmaceutical and medical supply categories. Chemical industry support may be needed to maintain production of essential disinfectants and sterilization products.

Market: Synthetic rubber prices up approximately 20% are raising PPE manufacturing costs for masks, gowns, and gloves. Alcohol-based sanitizer and disinfectant costs are increasing with isopropanol and ethanol tied to crude oil prices. Hospital infection prevention budgets are under pressure from concurrent cost increases across all infection control product categories.

Procurement: Shipping rerouting adds close to USD 933,000 per voyage for imported sterilization equipment and specialty chemicals. Chemical raw material procurement costs are rising from energy price increases affecting the chlor-alkali manufacturing process. Procurement teams are building strategic stocks of disinfectants and PPE while qualifying domestic chemical suppliers.